Access to care following Planned Parenthood's termination from Texas' Medicaid network: A qualitative study.

Objectives: This study aimed to explore Planned Parenthood Medicaid patients' experiences getting reproductive health care in Texas after the state terminated Planned Parenthood providers from its Medicaid program in 2021.

Study Design: Between January and September 2021, we recruited Medicaid patients who obtained care at Planned Parenthood health centers prior to the state termination using direct mailers, electronic messages, community outreach, and flyers in health centers. We conducted baseline and 2-month follow-up semistructured phone interviews about patients' previous experiences using Medicaid at Planned Parenthood and other providers and how the termination affected their care.

Minors' Experiences Accessing Confidential Contraception in Texas.

Purpose: Texas is one of 24 states that restricts minors' ability to obtain contraception without parental consent, unless they access confidential services at federally funded Title X clinics. This study explores Texas minors' reasons for and experiences seeking confidential contraception.

Methods: Between September 2020 and June 2021, we conducted in-depth phone interviews with 28 minors aged 15-17 years.

Evidence-based family planning services among publicly funded providers in Texas.

Background: Healthy Texas Women (HTW) is a fee-for-service family planning program that excludes affiliates of abortion providers. The HTW network includes providers who participate in Title X or the state Family Planning Program (FPP) and primary care providers without additional family planning funding (HTW-only). The objective of this study is to compare client volume and use of evidence-based practices among HTW providers.

Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.

Objectives: Assess preferences for and use of medication abortion in Texas after implementation of two policy changes: a 2013 state law restricting medication abortion and the FDA label change for mifepristone in 2016 nullifying some of this restriction.

Study Design: We analyzed surveys conducted in 2014 and 2018 with abortion patients at 10 Texas abortion facilities. We calculated the percentage of all respondents with an initial preference for medication abortion by survey year, and the type of abortion obtained or planned to obtain among those who were at <10 weeks of gestation.

Insurance Churn and Postpartum Health among Texas Women with Births Covered by Medicaid/CHIP.

Introduction: Insurance churn (changes in coverage) after childbirth is common in the United States, particularly in states that have not expanded Medicaid coverage. Although insurance churn may have lasting consequences for health care access, most research has focused on the initial weeks after a birth.

Methods: We analyzed data from a cohort study of postpartum Texans with pregnancies covered by public insurance (n = 1,489).